Works matching IS 10837159 AND DT 2016 AND VI 21 AND IP 6
Results: 22
Erratum: High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 1, doi. 10.1634/theoncologist.2015-0312
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 708, doi. 10.1634/theoncologist.2015-0440
- By:
- Publication type:
- Article
Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 771, doi. 10.1634/theoncologist.2015-0445
- By:
- Publication type:
- Article
A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 723, doi. 10.1634/theoncologist.2015-0492
- By:
- Publication type:
- Article
Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 666, doi. 10.1634/theoncologist.2015-0449
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 684, doi. 10.1634/theoncologist.2016-0030
- By:
- Publication type:
- Article
Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 664, doi. 10.1634/theoncologist.2016-0071
- By:
- Publication type:
- Article
New Frameworks to Assess Value of Cancer Care: Strengths and Limitations.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 654, doi. 10.1634/theoncologist.2016-0177
- By:
- Publication type:
- Article
The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 671, doi. 10.1634/theoncologist.2015-0470
- By:
- Publication type:
- Article
Systemic Therapy for Invasive Bladder Cancer: The Value Proposition.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 739, doi. 10.1634/theoncologist.2015-0429
- By:
- Publication type:
- Article
The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 692, doi. 10.1634/theoncologist.2015-0298
- By:
- Publication type:
- Article
Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 701, doi. 10.1634/theoncologist.2015-0455
- By:
- Publication type:
- Article
Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 745, doi. 10.1634/theoncologist.2015-0239
- By:
- Publication type:
- Article
Value: The Next Frontier in Cancer Care.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 651, doi. 10.1634/theoncologist.2016-0174
- By:
- Publication type:
- Article
Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
- Published in:
- 2016
- By:
- Publication type:
- Opinion
The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 716, doi. 10.1634/theoncologist.2015-0336
- By:
- Publication type:
- Article
Re-Evaluating Progression in an Era of Progress: A Review of First- and Second-Line Treatment Options in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 755, doi. 10.1634/theoncologist.2015-0396
- By:
- Publication type:
- Article
Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 731, doi. 10.1634/theoncologist.2015-0387
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-ResponsiveALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 762, doi. 10.1634/theoncologist.2015-0497
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2016
- Publication type:
- Correction Notice
Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 6, p. 676, doi. 10.1634/theoncologist.2015-0199
- By:
- Publication type:
- Article